{"id":"W4391838925","doi":"10.1038/s41409-024-02207-4","title":"Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program","year":2024,"lang":"en","type":"article","venue":"Bone Marrow Transplantation","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharmaceuticals Canada; Novartis Pharma","keywords":"Ruxolitinib; Medicine; Internal medicine; Graft-versus-host disease; Gastroenterology; Corticosteroid; Disease; Myelofibrosis; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001673957,0.0001011086,0.0002622618,0.0004115168,0.0001588418,0.0005086362,0.0002339932,0.0002429561,0.0004722193],"category_scores_gemma":[0.00315235,0.00008998524,0.0002010912,0.0009025279,0.0001712269,0.0003766862,0.0003542968,0.0003766386,0.00008804337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004433008,"about_ca_system_score_gemma":0.0005521399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002420507,"about_ca_topic_score_gemma":0.004104094,"domain_scores_codex":[0.9992386,0.0003080546,0.00008820241,0.00008330688,0.0001922588,0.00008964191],"domain_scores_gemma":[0.9967284,0.001019701,0.001488893,0.00008626655,0.0002694083,0.0004073166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001902487,0.0002453878,0.9562976,0.0000627535,0.00007132698,0.0001481467,0.0001413375,0.0001272295,0.000598366,0.00003057169,0.0004608711,0.03991388],"study_design_scores_gemma":[0.0001435839,0.001428968,0.9959975,0.00004148922,0.0001040893,0.0004334454,0.0001798114,0.0003135389,0.0003205505,0.00002285644,0.001008821,0.00000528374],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973551,0.001346377,0.00004366472,0.0002230194,0.000004401279,0.00002241205,0.0002608159,0.00000314589,0.0007410253],"genre_scores_gemma":[0.9986686,0.0006762473,0.0001083164,0.0001586199,0.00002144925,0.00001125551,0.0002857038,0.000001544225,0.00006836754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002420507,"threshold_uncertainty_score":0.00885278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01680985862668637,"score_gpt":0.2631552878661827,"score_spread":0.2463454292394963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}